Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy

Growth Hormone and IGF Research

Volumn 19, Issue 3, 2009, Pages 206-211

  Fernholm, R ^a   Thoren, M ^a   Hoybye, C ^a   Anderstam, B ^a   Pernow, Y ^a   Saaf, M ^a   Hall, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amino acids; Branched chain amino acids; Glutamate; Glutamine; Growth hormone deficiency; Growth hormone replacement therapy; Somatotropin

Indexed keywords

AMINO ACID; GLUTAMIC ACID; GLUTAMINE; HUMAN GROWTH HORMONE; ISOLEUCINE; LEUCINE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; ERYTHROCYTE LEVEL; EVENING DOSAGE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WEIGHT GAIN;

ADULT; AGED; AMINO ACIDS; CASE-CONTROL STUDIES; ERYTHROCYTES; FEMALE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; JAPAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67349151269     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.09.001     Document Type: Article

References (28)

1. Carrol P.V., Christ E.R., Bengtsson B.A., et al. Growth hormone deficiency in adulthood and the effect of growth hormone replacement: a review. Growth hormone research scientific committee. J. Clin. Endocrinol. Metab. 83 (1998) 382-395
2. Hilding A., Hall K., Wivall-Helleryd I.L., Sääf M., Melin A.L., and Thorén M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years compared with those in healthy subjects. J. Clin. Endocrinol. Metab. 84 (1999) 2013-2019
3. Johannsson G., Bjarnason R., Bramnert M., et al. The individual responsiveness to growth hormone (GH) is dependent on the level of GH-binding protein, body mass index, age, and gender. J. Clin. Endocrinol. Metab. 81 (1996) 1575-1581
4. Fernholm R., Bramnert M., Hägg E., et al. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J. Clin. Endocrinol. Metab. 85 (2000) 4104-4112
5. Lucidi P., Lauteri M., Lauteri S., et al. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J. Clin. Endocrinol. Metab. 83 (1998) 353-357
6. de Boer H., Blok G.J., Copp-Snijders L., Stuurman R., Baxter C., and van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on serum markers. J. Clin. Endocrinol. Metab. 81 (1996) 1371-1377
7. Thorén M., Hilding A., Baxter R.C., Degerblad M., Wivall-Helleryd I.-L., and Hall K. Serum insulin-like growth factor I (IGF-I), IGF binding protein-1 and -3 and the acid-labile subunit as serum markers of body composition during growth hormone therapy. J. Clin. Endocrinol. Metab. 82 (1997) 223-228
8. Tom A., and Nair K.S. Assessment of branched- chain amino acids and potentials for biomarkers. J. Nutr. 136 (2006) S324-S330
9. Divino Filho J.C., Hazel S.J., Furst P., Bergström J., and Hall K. Glutamate concentration in plasma, erythrocytes and muscle in relation to plasma levels of insulin-like growth factor (IGF)-I, IGF binding protein-1 and insulin in patients on haemodialysis. J. Endocrinol. 156 (1998) 519-527
10. Fujita Y., Yoshimura Y., and Inoue G. Effect of low- protein diets on free amino acids in plasma of young men: effect of protein quality with maintenance or excess energy intake. J. Nutr. Sci. Vitaminol. (Tokyo) 24 (1978) 297-309
11. Polge A., Bancel E., Bellet H., et al. Plasma amino acid concentrations in elderly patients with protein energy malnutrition. Age Ageing 26 (1997) 457-462
12. Felig P., Wahren J., and Rääf L. Evidence of inter-organ amino-acid transport by blood cells in humans. Proc. Natl. Acad. Sci. USA 70 (1973) 1775-1779
13. Hagenfeldt L., and Arvidsson A. The distribution of amino acids in plasma and erythrocytes. Clin. Chim. Acta 100 (1980) 133-141
14. Suliman M.E., Anderstam B., and Bergström J. Evidence of taurine depletion and accumulation of cysteinsulfinic acid in chronic dialysis patients. Kidney Int. 50 (1996) 1713-1717
15. Flugel-Link R.M., Jones M.R., and Kopple J.D. Red cell and plasma amino acid concentrations in renal failure. J. Parenter. Enter. Nutr. 7 (1983) 450-456
16. Bang P., Wivall I.L., Eriksson U., Sara V., and Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvements of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol. (Kbh) 124 (1991) 620-629
17. Póvoa G., Roovete A., and Hall K. Cross-reaction of somatomedin- binding protein, a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol. (Kbh) 124 (1991) 563-570
18. Tothill P., Avenell A., Love J., and Reid D.M. Comparison between Hologic, Lunar and Norland dual-energy X-ray absorptiometers and other techniques used for whole body soft tissue measurements. Eur. J. Clin. Nutr. 48 (1994) 781-794
19. Armstrong M.D., and Stave U. A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism 22 (1973) 561-569
20. Milsom J.P., Morgan M.Y., and Sherlock S. Factors affecting plasma amino acid concentrations in control subjects. Metabolism 28 (1979) 313-319
21. Hiroshige K., Sonta T., Suda T., Kanegae K., and Othini A. Oral supplementation of branched-chain amino acids improves nutritional status in patients on chronic hemodialysis. Nephrol. Dial. Transpl. 16 (2001) 1856-1862
22. Hack V., Stutz O., Kinscherf R., et al. Elevated venous glutamate levels in (pre) catabolic conditions result at least partly from a decreased glutamate transport activity. J. Mol. Med. 74 (1996) 337-343
23. Nygren J., and Nair K.S. Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy subjects. Diabetes 52 (2003) 1377-1385
24. Smith K., Reynolds N., Downie S., Patel A., and Rennie M.J. Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein. Am. J. Physiol. Endocrinol. Metab. 275 (1998) E73-E78
25. Cuthbertson D., Smith K., and Babraj J. Anabolic signaling deficits underlie amino acid resistance of wasting aging muscle. FASEB J. 19 (2005) 422-424 (E-pub dec 2004)
26. Norrelund H., Moller N., Nair K.S., Christiansen J.S., and Jorgensen J.O. Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J. Clin. Endocrinol. Metab. 86 (2001) 3120-3129
27. Norrelund H., Nair K.S., Jorgensen J.O., Christiansen J.S., and Moller N. The protein retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50 (2001) 96-104
28. Norrelund H., Borglum J., Jorgensen J.O., Richelsen J.O., Moller N., Nair K.S., and Christiansen J.S. Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women. Clin. Endocrinol. (Oxf) (2001) 305-312